Arix Bioscience, Russ Mould on the Fed & Paul Hill on Boohoo
Episode 1972, Jul 10, 2020, 01:10 PM
Arix Bioscience discusses one of their portfolio company's Atox Bio, which plans a new drug application submission for Q3. Russ Mould talks about the FED. Paul Hill discusses Boohoo & Rosslyn Data Technologies.
On The Vox Markets Podcast Today: 10th July 2020
Jonathan Tobin Managing Director Arix Bioscience #ARIX discusses one of their portfolio company's Atox Bio, which plans a new drug application submission for Q3.
Russ Mould, Investment Director at stockbroker AJ Bell talks about the FED and their influence on the market.
(Interview starts at 14 minutes 52 seconds)
Paul Hill, full time investor and equity analyst gives his view on: Boohoo (BOO) Rosslyn Data Technologies (RDT)
(Interview starts at 25 minutes 50 seconds)
Plus the Top 5 Most Followed Companies & the Top 5 Most read RNS’s on Vox Markets in the last 24 hours.
Vox Markets is revolutionising the way companies engage with shareholders and the stock market at large. By aggregating IR and digital content onto one secure and compliant platform, Vox Markets has established itself as the go-to resource for the investment community.
#VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Investments #Finance #Business #Podcast